Kiffik Biomedical, Inc. — Form D/A
Kiffik Biomedical, Inc. of PROVIDENCE, RI, a company, filed a Form D amendment with the SEC on 2022-06-24. The offering totals $15.0M, of which $830K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-24
- Form: D/A
- Accession: 0001493152-22-017673
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $830K
- Remaining: $14.2M
- Minimum investment: $10K
- Investors: 12
- Date of first sale: 2021-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-449745
Issuer
- Name: Kiffik Biomedical, Inc.
- CIK: 0001932760
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 128 DORRANCE STREET, 6TH FLOOR, PROVIDENCE, RI, 02903
- Phone: 516-246-4000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| George Cagna | Director | Providence, RI |
| Blake Carver | Director | Providence, RI |
| Brian Dougan | Director | Providence, RI |
| Nicholas Marr | Director | Providence, RI |
| Howard Peterson | Director | Providence, RI |
| George Cagna | Executive Officer | Providence, RI |
| Brian Dougan | Executive Officer | Providence, RI |
| Nicholas Marr | Executive Officer | Providence, RI |
| Howard Peterson | Executive Officer | Providence, RI |
| George Cagna | Promoter | Providence, RI |
| Brian Dougan | Promoter | Providence, RI |
| Nicholas Marr | Promoter | Providence, RI |
Other filings by this issuer (1)
More